NKARTA, INC.

Profile

Company Names

NKARTA, INC.

Addresses

6000 SHORELINE COURT, SUITE 102, SOUTH SAN FRANCISCO, CA 94080

Phone Numbers

650-215-0385

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$43,899,296.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2019-08-27 
$43,899,296.00 
$114,636,678.00 
$70,737,382.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
TIBA 
 
AYNECHI 
DIRECTOR
THESAN PHARMACEUTICALS, INC.   |  IRHYTHM TECHNOLOGIES, INC.   |  ANAPTYSBIO INC   |  GENOA PHARMACEUTICALS, INC.   |  MIRUM PHARMACEUTICALS, INC.   |  ARCELLX, INC.   |  NKARTA, INC.   |  AVALYN PHARMA INC.   |  SPRUCE BIOSCIENCES, INC.   |  ARISTEA THERAPEUTICS, INC.   |  MBX BIOSCIENCES, INC.   |  REZO THERAPEUTICS, INC.   |  RAY THERAPEUTICS, INC.
FOUAD 
 
AZZAM 
DIRECTOR
HARVEST AUTOMATION INC   |  COBALT TECHNOLOGIES INC   |  CELLADON CORP   |  SEAHORSE BIOSCIENCE INC   |  ILLUMINOSS MEDICAL INC   |  ROTATION MEDICAL INC   |  BIOCLIN THERAPEUTICS, INC.   |  RAINIER THERAPEUTICS, INC.   |  NKARTA, INC.   |  ENDOTRONIX INC   |  EQT HEALTH ECONOMICS 3 COOPERATIEF U.A.   |  NEUROS MEDICAL, INC.
ALI 
 
BEHBAHANI 
DIRECTOR
ROTATION MEDICAL INC   |  DENALI MEDICAL II, INC.   |  MINERVA SURGICAL INC   |  PROSPEX MEDICAL III, INC.   |  OCULEVE, INC.   |  CVRX INC   |  IVANTIS, INC.   |  ADAPTIMMUNE LTD   |  CARDIONOMIC, INC.   |  CVRX, INC.   |  SOLACE THERAPEUTICS INC   |  CRISPR THERAPEUTICS AG   |  OYSTER POINT PHARMA, INC.   |  GENOCEA BIOSCIENCES, INC.   |  BLACK DIAMOND THERAPEUTICS, INC.   |  SPYGLASS OPHTHALMICS, INC.   |  ARCELLX, INC.   |  NKARTA, INC.   |  NEA BH SPV, L.P.   |  NEA BH SPV II, L.P.   |  MONTE ROSA THERAPEUTICS, INC.   |  858 THERAPEUTICS, INC.   |  NEW ENTERPRISE ASSOCIATES 18, L.P.   |  NEA 18 VENTURE GROWTH EQUITY, L.P.   |  FIRSTLIGHT BIO, INC.   |  NEXO THERAPEUTICS, INC.   |  LAUNCHPAD THERAPEUTICS, INC.   |  NEA SH SPV, L.P.   |  SPYGLASSPHARMA, INC.   |  NEA RP SPV, L.P.   |  NEA CH SPV, L.P.   |  NEA TS 2024 SPV, L.P.   |  NEA SECONDARY OPPORTUNITY FUND, L.P.   |  TUNE THERAPEUTICS, INC.
JILL 
 
CARROLL 
DIRECTOR
VASCULOX, INC.   |  TIOMA THERAPEUTICS, INC.   |  ARCELLX, INC.   |  NKARTA, INC.   |  PANDION THERAPEUTICS HOLDCO LLC   |  ODYSSEY THERAPEUTICS, INC.   |  AVALYN PHARMA INC.   |  AIRNEXIS THERAPEUTICS, INC.
MICHAEL 
 
DYBBS 
DIRECTOR
VERSARTIS, INC.   |  PRINCIPIA BIOPHARMA INC.   |  SAMSARA BIOCAPITAL, L.P.   |  SUTRO BIOPHARMA INC   |  NKARTA, INC.   |  565 SPV I, L.P.   |  LEVO THERAPEUTICS, INC.   |  DELFI DIAGNOSTICS, INC.   |  ABCURO, INC.   |  SAMSARA OPPORTUNITY FUND, L.P.
PAUL 
 
HASTINGS 
EXECUTIVE OFFICER, DIRECTOR
CERIMON PHARMACEUTICALS, INC.   |  RELYPSA INC   |  NKARTA, INC.   |  VIACYTE INC.
MATTHEW 
 
PLUNKETT 
EXECUTIVE OFFICER
NKARTA, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-09-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#